{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:34:43Z","timestamp":1792665283551,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK131033"],"award-info":[{"award-number":["R01 DK131033"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["01GM1904A"],"award-info":[{"award-number":["01GM1904A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["01GM2204A"],"award-info":[{"award-number":["01GM2204A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jhepr.2025.101625","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:41:02Z","timestamp":1760002862000},"page":"101625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Challenges in the diagnosis and treatment of genetic cholestasis in adults"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-0150","authenticated-orcid":false,"given":"Richard J.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vilarinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-0186","authenticated-orcid":false,"given":"Rosa","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-7662","authenticated-orcid":false,"given":"Verena","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101625_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0046-8177(70)80002-8","article-title":"Pathophysiology of cholestasis","volume":"1","author":"Popper","year":"1970","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhepr.2025.101625_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","article-title":"Progressive familial intrahepatic cholestasis","volume":"22","author":"Bull","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.30826","article-title":"Exome sequencing in clinical hepatology","volume":"70","author":"Vilarinho","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104747","article-title":"Advancing diagnosis and management of liver disease in adults through exome sequencing","volume":"95","author":"Zheng","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jhepr.2025.101625_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","article-title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing","volume":"53","author":"Vitale","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101625_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","article-title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants","volume":"67","author":"Dr\u00f6ge","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib8","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib9","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.32437","article-title":"Cholestatic liver diseases of genetic etiology: advances and controversies","volume":"75","author":"Ibrahim","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cld.2018.06.006","article-title":"Inborn errors of bile acid metabolism","volume":"22","author":"Heubi","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1053\/gast.2002.36587","article-title":"Functional expression of the canalicular bile salt export pump of human liver","volume":"123","author":"Noe","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2025.101625_bib14","doi-asserted-by":"crossref","first-page":"39411","DOI":"10.1074\/jbc.M106340200","article-title":"Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450","volume":"276","author":"Schuetz","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2025.101625_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib18","article-title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","volume":"5","author":"Felzen","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101625_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/hep.20627","article-title":"Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP\/ABCB11","volume":"41","author":"Hayashi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2004.04.065","article-title":"Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11","volume":"127","author":"van Mil","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(01)00299-9","article-title":"Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum","volume":"36","author":"van Ooteghem","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","article-title":"Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy","volume":"133","author":"Van Mil","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101625_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.22683","article-title":"Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing","volume":"49","author":"Byrne","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21214","article-title":"Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver","volume":"44","author":"Meier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0003-9861(03)00098-5","article-title":"Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis","volume":"413","author":"Muhlfeld","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jhepr.2025.101625_bib27","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jhep.2005.09.017","article-title":"Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy","volume":"44","author":"Vallejo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/03602530903492004","article-title":"Role of the bile salt export pump, BSEP, in acquired forms of cholestasis","volume":"42","author":"Stieger","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhepr.2025.101625_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101625_bib31","doi-asserted-by":"crossref","first-page":"9947","DOI":"10.1074\/jbc.M808667200","article-title":"Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content","volume":"284","author":"Paulusma","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2025.101625_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.21212","article-title":"Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport","volume":"44","author":"Paulusma","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng0398-219","article-title":"A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis","volume":"18","author":"Bull","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib34","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.bbamcr.2016.06.005","article-title":"The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator","volume":"1863","author":"van der Mark","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhepr.2025.101625_bib35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31787","article-title":"Impact of genotype, serum bile acids, and surgical biliary diversion on native liver survival in FIC1 deficiency","volume":"74","author":"van Wessel","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1026537","article-title":"Mutations in TJP2, encoding zona occludens 2, and liver disease","volume":"3","author":"Sambrotta","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jhepr.2025.101625_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng1147","article-title":"Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT","volume":"34","author":"Carlton","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib39","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1053\/j.gastro.2021.01.027","article-title":"Protective functions of ZO-2\/Tjp2 expressed in hepatocytes and cholangiocytes against liver injury and cholestasis","volume":"160","author":"Xu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib40","article-title":"Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101625_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/HEP.0000000000000828","article-title":"Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasis","volume":"80","author":"Lal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","article-title":"Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants","volume":"21","author":"Maddirevula","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/liv.14422","article-title":"Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: clinical, histological and ultrastructural characterization","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101625_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2003.12.050","article-title":"Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases","volume":"314","author":"Quesada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167624","article-title":"Loss of hepatocyte Usp53 protects mice from a form of xenobiotic-induced liver injury","volume":"1871","author":"Ding","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008984","article-title":"Strain background modifies phenotypes in the ATP8B1-deficient mouse","volume":"5","author":"Shah","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2025.101625_bib47","first-page":"1489","article-title":"Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein","volume":"38","author":"Wang","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib48","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1523\/JNEUROSCI.1965-15.2015","article-title":"Progressive hearing loss in mice carrying a mutation in Usp53","volume":"35","author":"Kazmierczak","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.jhepr.2025.101625_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/cge.13638","article-title":"Whole-exome sequencing identifies rare pathogenic and candidate variants in sporadic Chinese Han deaf patients","volume":"97","author":"Zou","year":"2020","journal-title":"Clin Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib50","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/01945998211029544","article-title":"A genome-first approach to rare variants in dominant postlingual hearing loss genes in a large adult population","volume":"166","author":"Ahmadmehrabi","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jhepr.2025.101625_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jpeds.2020.01.064","article-title":"Biallelic mutations in the LSR gene cause a novel type of infantile intrahepatic cholestasis","volume":"221","author":"Uehara","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhepr.2025.101625_bib52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1242\/jcs.072058","article-title":"LSR defines cell corners for tricellular tight junction formation in epithelial cells","volume":"124","author":"Masuda","year":"2011","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jhepr.2025.101625_bib53","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/j.1432-1033.2004.04223.x","article-title":"Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-\/- embryos at 12.5 to 14.5 days of gestation","volume":"271","author":"Mesli","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jhepr.2025.101625_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.28779","article-title":"MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease","volume":"65","author":"Gonzales","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib55","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.29020","article-title":"Defects in myosin VB are associated with a spectrum of previously undiagnosed low gamma-glutamyltransferase cholestasis","volume":"65","author":"Qiu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib56","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ng.225","article-title":"MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity","volume":"40","author":"Muller","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/humu.21224","article-title":"Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model","volume":"31","author":"Ruemmele","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jhepr.2025.101625_bib58","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hep.26974","article-title":"MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease","volume":"60","author":"Girard","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030481","article-title":"Congenital diarrhea and cholestatic liver disease: phenotypic spectrum associated with MYO5B mutations","volume":"10","author":"Aldrian","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/liv.15104","article-title":"MYO5B-associated diseases: novel liver-related variants and genotype-phenotype correlation","volume":"42","author":"Wang","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101625_bib61","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1172\/JCI71651","article-title":"Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease","volume":"124","author":"Knowles","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2025.101625_bib62","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1091\/mbc.12.6.1843","article-title":"Myosin vb is associated with plasma membrane recycling systems","volume":"12","author":"Lapierre","year":"2001","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jhepr.2025.101625_bib63","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114563","article-title":"A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis","volume":"13","author":"Pan","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154113","article-title":"SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surface","volume":"7","author":"Zhao","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhepr.2025.101625_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.matbio.2023.06.006","article-title":"SEMA7a primes integrin alpha5beta1 engagement instructing fibroblast mechanotransduction, phenotype and transcriptional programming","volume":"121","author":"Hu","year":"2023","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jhepr.2025.101625_bib66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12964-022-01024-w","article-title":"Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin beta1 and mediates inflammation","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jhepr.2025.101625_bib67","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.25992","article-title":"alpha5 beta1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes","volume":"57","author":"Gohlke","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib68","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajpath.2020.10.011","article-title":"Integrin beta1 establishes liver microstructure and modulates transforming growth factor beta during liver development and regeneration","volume":"191","author":"Masuzaki","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2025.101625_bib69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.gastro.2021.03.026","article-title":"Deleterious variants in ABCC12 are detected in idiopathic chronic cholestasis and cause intrahepatic bile duct loss in model organisms","volume":"161","author":"Pham","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib70","article-title":"A link between intrahepatic cholestasis and genetic variations in intracellular trafficking regulators","volume":"10","author":"Li","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jhepr.2025.101625_bib71","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng1325","article-title":"Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome","volume":"36","author":"Gissen","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng.538","article-title":"Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization","volume":"42","author":"Cullinane","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib73","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/brain\/awt012","article-title":"MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy","volume":"136","author":"Martinelli","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jhepr.2025.101625_bib74","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/gim.2017.260","article-title":"SCYL1 variants cause a syndrome with low gamma-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)","volume":"20","author":"Lenz","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib75","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jhep.2017.01.001","article-title":"Vps33b is crucial for structural and functional hepatocyte polarity","volume":"66","author":"Hanley","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib76","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.str.2021.05.013","article-title":"Evidence for a credit-card-swipe mechanism in the human PC floppase ABCB4","volume":"29","author":"Prescher","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.jhepr.2025.101625_bib77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2025.101625_bib78","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0016-5085(94)90083-3","article-title":"Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage","volume":"107","author":"Puglielli","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib79","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2025.101625_bib80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2025.101625_bib81","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.3247","article-title":"Large-scale whole-genome sequencing of the Icelandic population","volume":"47","author":"Gudbjartsson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib82","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ejhg.2011.186","article-title":"First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis","volume":"20","author":"Pasmant","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.20022","article-title":"Spontaneous cholecysto- and hepatolithiasis in Mdr2-\/- mice: a model for low phospholipid-associated cholelithiasis","volume":"39","author":"Lammert","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib84","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2001.23947","article-title":"MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis","volume":"120","author":"Rosmorduc","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib86","article-title":"Low-phospholipid-associated cholelithiasis syndrome: prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101625_bib87","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/liv.14662","article-title":"Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma","volume":"40","author":"de Vries","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101625_bib88","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(05)77221-4","article-title":"Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy","volume":"353","author":"Jacquemin","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101625_bib89","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib90","article-title":"Outcomes of 38 patients with PFIC3: impact of genotype and of response to ursodeoxycholic acid therapy","volume":"5","author":"Gonzales","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101625_bib91","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.111145398","article-title":"All kinesin superfamily protein, KIF, genes in mouse and human","volume":"98","author":"Miki","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2025.101625_bib92","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrm2774","article-title":"Kinesin superfamily motor proteins and intracellular transport","volume":"10","author":"Hirokawa","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhepr.2025.101625_bib93","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jpeds.2021.09.019","article-title":"KIF12 variants and disturbed hepatocyte polarity in children with a phenotypic spectrum of cholestatic liver disease","volume":"240","author":"Stalke","year":"2022","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhepr.2025.101625_bib94","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep4.1320","article-title":"Recessive mutations in KIF12 cause high gamma-glutamyltransferase cholestasis","volume":"3","author":"Unlusoy","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib95","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jmedgenet-2019-106706","article-title":"Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis","volume":"58","author":"Luan","year":"2021","journal-title":"J Med Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib96","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg-2023-109779","article-title":"ZFYVE19 deficiency: a ciliopathy involving failure of cell division, with cell death","volume":"61","author":"Yang","year":"2024","journal-title":"J Med Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-021-01775-8","article-title":"A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant","volume":"16","author":"Mandato","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib98","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/humu.23031","article-title":"DCDC2 mutations cause neonatal sclerosing cholangitis","volume":"37","author":"Girard","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jhepr.2025.101625_bib99","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jhep.2016.07.017","article-title":"Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis","volume":"65","author":"Grammatikopoulos","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1053\/j.gastro.2004.07.022","article-title":"Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease","volume":"127","author":"Hadj-Rabia","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib101","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/hep.30841","article-title":"Plectin mutations in progressive familial intrahepatic cholestasis","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101231","article-title":"Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations","volume":"26","author":"Maddirevula","year":"2024","journal-title":"Genet Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib103","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12072-023-10578-x","article-title":"Management of adults with Alagille syndrome","volume":"17","author":"Ayoub","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2025.101625_bib104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cld.2022.03.002","article-title":"Alagille syndrome: current understanding of pathogenesis, and challenges in diagnosis and management","volume":"26","author":"Ayoub","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib105","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1007\/s10620-022-07416-9","article-title":"ABCB4 mutations in adults cause a spectrum cholestatic disorder histologically distinct from other biliary disease","volume":"67","author":"Sinha","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2025.101625_bib106","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib107","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","article-title":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","volume":"73","author":"Stattermayer","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib108","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.dld.2020.12.003","article-title":"ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed","volume":"53","author":"Avena","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101625_bib109","article-title":"A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome","volume":"4","author":"Biyoukar","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101625_bib110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.gcb.2010.04.011","article-title":"The cholangiographic features of severe forms of ABCB4\/MDR3 deficiency-associated cholangiopathy in adults","volume":"34","author":"Poupon","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jhepr.2025.101625_bib111","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bpg.2018.06.007","article-title":"Symptoms of PBC - pathophysiology and management","volume":"34\u201335","author":"Khanna","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101625_bib112","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2024.04.006","article-title":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib113","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000408","article-title":"Genetics of liver disease in adults","volume":"8","author":"Konkwo","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib114","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/hep.32364","article-title":"Genomic medicine for liver disease","volume":"76","author":"Zheng","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41431-022-01162-2","article-title":"Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis","volume":"30","author":"Ewans","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib116","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41431-019-0401-x","article-title":"Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes","volume":"27","author":"Schmitz-Abe","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib117","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41588-025-02125-1","article-title":"Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency","volume":"57","author":"Brzozowska","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib118","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41588-025-02151-z","article-title":"The interplay between germline and somatic variants in alpha-1 anti-trypsin deficiency liver disease","volume":"57","author":"Vilarinho","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101625_bib119","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jhep.2023.03.030","article-title":"Hepatology Genome Rounds: an interdisciplinary approach to integrate genomic data into clinical practice","volume":"79","author":"Chung","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mpdhp.2022.10.004","article-title":"Approach to the liver biopsy diagnosis of adult cholangiopathies","volume":"29","author":"Nalbantoglu","year":"2023","journal-title":"Diagn Histopathology"},{"key":"10.1016\/j.jhepr.2025.101625_bib121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-012-1202-6","article-title":"Aspects of liver pathology in adult patients with MDR3\/ABCB4 gene mutations","volume":"460","author":"Wendum","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhepr.2025.101625_bib122","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/labinvest.3700371","article-title":"Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver","volume":"86","author":"Dombrowski","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhepr.2025.101625_bib123","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib124","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1665-2681(19)30771-9","article-title":"Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3","volume":"14","author":"Frider","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib125","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib126","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101625_bib127","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000092","article-title":"Native liver survival in bile salt export pump deficiency: results of a retrospective cohort study","volume":"7","author":"Pfister","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17474124.2022.2032660","article-title":"Biliary diversion in progressive familial intrahepatic cholestasis: a systematic review and meta-analysis","volume":"16","author":"Bolia","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib130","article-title":"Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis","volume":"5","author":"Thompson","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101625_bib131","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/hep4.1980","article-title":"Maralixibat for the treatment of PFIC: long-term, IBAT inhibition in an open-label, Phase 2 study","volume":"6","author":"Loomes","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101625_bib132","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2468-1253(24)00080-3","article-title":"Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Miethke","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101625_bib133","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101625_bib134","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101625_bib135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.metabol.2008.08.005","article-title":"Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis","volume":"58","author":"Nagasaka","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2025.101625_bib136","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/liv.15200","article-title":"Extrahepatic manifestations of progressive familial intrahepatic cholestasis syndromes: presentation of a case series and literature review","volume":"42","author":"Pfister","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101625_bib137","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11377-023-00727-x","article-title":"Angeborene Cholestasesyndrome im Erwachsenenalter: Relevantes f\u00fcr Diagnostik und Therapie","volume":"18","author":"Dr\u00f6ge","year":"2023","journal-title":"Die Gastroenterologie"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:43:03Z","timestamp":1778096583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925003076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2589555925003076"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101625","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the diagnosis and treatment of genetic cholestasis in adults","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101625"}}